Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate

BACKGROUND: Neuroendocrine carcinomas of the prostate (NEPCs) are rare tumors with poor prognosis. While platinum and etoposide-based chemotherapy regimens (PE) are commonly applied in first-line for advanced disease, evidence for second-line therapy and beyond is very limited. METHODS: Retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Apostolidis, Leonidas, Nientiedt, Cathleen, Winkler, Eva Caroline, Berger, Anne Katrin, Kratochwil, Clemens, Kaiser, Annette, Becker, Anne-Sophie, Jäger, Dirk, Hohenfellner, Markus, Hüttenbrink, Clemens, Pahernik, Sascha, Distler, Florian A., Grüllich, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343754/
https://www.ncbi.nlm.nih.gov/pubmed/30713600
http://dx.doi.org/10.18632/oncotarget.26523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343754/
https://www.ncbi.nlm.nih.gov/pubmed/30713600
http://dx.doi.org/10.18632/oncotarget.26523

Ejemplares similares